Project 1: Therapeutic Potential of Kappa Opioid Receptor Antagonists in the Treatment of Depression (Chavkin) | Conte Center
Major Depressive Disorder and Kappa Opioid Receptor
PDF) Kappa opioid receptor antagonism: Are opioids the answer for treatment resistant depression?
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA)
The Role of Dynorphin and the Kappa Opioid Receptor in Schizophrenia and Major Depressive Disorder: A Translational Approach | SpringerLink
Major Depressive Disorder and Kappa Opioid Receptor
Kappa Opiate Receptor Agonist - an overview | ScienceDirect Topics
Antagonists of the kappa opioid receptor - ScienceDirect
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse - ScienceDirect
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience
Kappa Opioids, Salvinorin A and Major Depressive Disorder
Fluorine-18-Labeled Antagonist for PET Imaging of Kappa Opioid Receptors | ACS Chemical Neuroscience
Development of κ opioid receptor antagonists. | Semantic Scholar
Kappa Opioid Receptors in the Pathology and Treatment of Major Depressive Disorder | SpringerLink
Discovery of Small Molecule Kappa Opioid Receptor Agonist and Antagonist Chemotypes through a HTS and Hit Refinement Strategy | ACS Chemical Neuroscience
κ-opioid receptor - Wikipedia
Dynorphin, stress, and depression | Semantic Scholar
Opioid Agonists and Antagonists | Anesthesia Key
Psychoactives | Free Full-Text | The Role of the Dynorphin/Kappa Opioid Receptor System in the Actions of Alcohol